Importantly, however, because of the lack of a control arm, in which a therapeutic intervention was not administered, the more rapid progression may, at least to a certain degree, reflect a more aggressive inherent behaviour of the HER2-overexpressing tumours (De Laurentiis et al. 2005). This evidence concerns the gene ERBB2 and neoplasm.